CTIS2023-509286-20-00
Active, not recruiting
Phase 1
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory viruses
Akershus University Hospital0 sites400 target enrollmentApril 12, 2024
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Viral respiratory tract infection
- Sponsor
- Akershus University Hospital
- Enrollment
- 400
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hospitalized, Adults 18 year or older, Moderately severe disease (CRB65 \= 2 at time of inclusion), Nasopharyngeal swab positive for influenza virus, parainfluenza virus, respiratory syncytial virus (RSV) or human metapneumovirus (hMPV), On antibiotic therapy as instituted by the receiving physician from the emergency department, Signed informed consent must be obtained and documented according to ICH GCP, and national/local regulations.
Exclusion Criteria
- •Requiring ICU admission at screening, Time from initiation of antibiotic therapy to screening \>48 hours, Requiring high\-flow oxygen therapy or non\-invasive ventilation at screening, Signs of severe pneumonia (abscesses, massive pleural effusion, a well\-defined lobar infiltrate on chest X\-ray strongly suggestive of bacterial etiology), Not immunocompetent (i.e. on active chemotherapy, corticosteroid therapy equaling \= 20 mg prednisolone daily for \= 4 weeks, chronic immunosuppression due to solid organ transplant), SARS\-CoV\-2 positive, Bacteremia, Urine antigen test positive for legionella, Any other infection necessitating antibiotic treatment, Antibiotic use for assumed airway infection within the last 24 hours before admission to hospital
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The ATHENIAN Study: A clinical trial investigating the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory virusesPatients with viral respiratory tract infection (influenza virus, parainfluenza virus, respiratory syncytial virus or human metapneumovirus)Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2021-004248-11-NOAkershus University Hospital400
Active, not recruiting
Phase 1
ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONSCommunity acquired pneumoniaMedDRA version: 20.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2019-001873-10-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS310
Recruiting
Phase 4
Antibiotic Therapy in Viral Airway InfectionsInfectious DiseaseInfluenzaRespiratory Syncytial Virus (RSV)Respiratory Tract InfectionsNCT05045612University Hospital, Akershus380
Completed
Phase 2
Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as ParameterRespiratory Tract InfectionNCT00688610Hannover Medical School571
Active, not recruiting
Phase 1
Antibiotics for chest infections in children consulting with the GPRespiratory tract infections in children aged between 6 months and 12 yearsMedDRA version: 20.1Level: LLTClassification code 10066740Term: Acute respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10024968Term: Lower respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2015-002455-97-GBniversity of Southampton938